← Every applicant
Sagent Pharms Inc FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CYCLOPHOSPHAMIDENew drugJul 17, 2023INJECTABLE, INJECTION |
| EPHEDRINE SULFATENew drugMar 9, 2023SOLUTION, INTRAVENOUS |
| NEOSTIGMINE METHYLSULFATENew drugFeb 17, 2023SOLUTION, INTRAVENOUS |
| CYANOCOBALAMINNew drugNov 15, 2022INJECTABLE, INJECTION |
| SUCCINYLCHOLINE CHLORIDENew drugMar 29, 2021INJECTABLE, INJECTION |
| PIPERACILLIN AND TAZOBACTAMNew drugFeb 16, 2021INJECTABLE, INJECTION |
| PIPERACILLIN AND TAZOBACTAMNew drugFeb 16, 2021INJECTABLE, INJECTION |